Page last updated: 2024-11-12

brevetoxin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

brevetoxin B: from dinoflagellate Gymnodinium breve [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10865865
CHEMBL ID413858
CHEBI ID80770
SCHEMBL ID869360
MeSH IDM0127914

Synonyms (22)

Synonym
pbtx-2
brevetoxin pbtx-2, ptychodiscus brevis
brevetoxin b
brevetoxin 2
79580-28-2
CHEMBL413858 ,
chebi:80770 ,
2-{[(1r,3s,5r,7s,9r,11s,12s,14r,16r,18s,20r,21z,24s,26r,28s,30r,31r,33s,35r,37s,42r,44s,46r,48s)-12-hydroxy-1,3,11,24,31,41,44-heptamethyl-39-oxo-2,6,10,15,19,25,29,34,38,43,47-undecaoxaundecacyclo[26.22.0.0^{3,26}.0^{5,24}.0^{7,20}.0^{9,18}.0^{11,16}.0^{
bdbm50172364
brevetoxin pbtx-2
8wbn7k7t6z ,
SCHEMBL869360
brevetoxin pbtx-2-20c
DTXSID20879997
Q27149820
brevetoxin-2
LYTCVQQGCSNFJU-FGRVLNGBSA-N
brevetoxin-2;pbtx-2
HY-12546
CS-0012002
2-[[(1r,3s,5r,7s,9r,11s,12s,14r,16r,18s,20r,21z,24s,26r,28s,30r,31r,33s,35r,37s,42r,44s,46r,48s)-12-hydroxy-1,3,11,24,31,41,44-heptamethyl-39-oxo-2,6,10,15,19,25,29,34,38,43,47-undecaoxaundecacyclo[26.22.0.03,26.05,24.07,20.09,18.011,16.030,48.033,46.035,
AKOS040755026

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Brevetoxin B (PbTx2) treated rats showed a two to three-fold increase in the amount of DNA in the comet tails, indicating that brevetoxin has in vivo clastogenic activity."( Brevetoxin B is a clastogen in rats, but lacks mutagenic potential in the SP-98/100 Ames test.
Leighfield, TA; Muha, N; Ramsdell, JS, 2009
)
2.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ciguatoxinCiguatoxins are cyclic polyether toxins, derived from marine dinoflagellates, which are responsible for the symptoms of ciguatera poisoning. Ingestion of tropical and subtropical fin fish contaminated by ciguatoxins results in an illness characterised by neurological, cardiovascular and gastrointestinal disorders.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID1660540Neurotoxicity in 4 to 5 hpf stage wild type zebrafish AB embryo assessed as induction of head butting at 4.5 to 22 nM under 14 hrs light and 10 hrs dark condition and measured at 5 dpf stage by microscopic analysis
AID690191Inhibition of MTX-induced 45Ca2+ influx in rat glioma C6 cells2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Artificial ladder-shaped polyethers that inhibit maitotoxin-induced Ca2+ influx in rat glioma C6 cells.
AID1660543Neurotoxicity in 4 to 5 hpf stage wild type zebrafish AB embryo assessed as reduction in spontaneous coiling frequency at 4.5 to 22 nM under 14 hrs light and 10 hrs dark condition and measured at 24 hpf stage by microscopic analysis
AID1774641Inhibition of Karenia brevis TrxR assessed as reduction in substrate reduction at 40 uM using DTNB as a substrate incubated for 60 mins in the presence of NADPH followed by substrate addition measured for 5 mins by absorbance based assay relative to contr2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
AID1774647Binding affinity to rat TrxR1 assessed as adduct formation at 7.2 uM by LC-MS/MS analysis2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
AID376746Toxicity against Gambusia affinis assessed as time required for death at 1 ug/ml after 24 hrs2005Journal of natural products, Jan, Volume: 68, Issue:1
A new polyether ladder compound produced by the dinoflagellate Karenia brevis.
AID254852Inhibitory concentration against synaptosomes using [3H]PbTx-32005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry.
AID477875Toxicity in mosquito fish assessed as time required for mortality at 200 nM2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Characterization of tamulamides A and B, polyethers isolated from the marine dinoflagellate Karenia brevis.
AID1774644Inhibition of Karenia brevis TrxR assessed as reduction in substrate reduction at 40 uM using GSSG as a substrate incubated for 60 mins in the presence of NADPH followed by substrate addition measured for 30 mins by absorbance based assay relative to cont2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
AID1660538Toxicity in 4 to 5 hpf stage wild type zebrafish AB embryo assessed as induction of bradycardia at 4.5 to 22 nM under 14 hrs light and 10 hrs dark condition and measured at 3 dpf stage by microscopic analysis
AID1660541Neurotoxicity in 4 to 5 hpf stage wild type zebrafish AB embryo assessed as induction of motor incoordination at 4.5 to 22 nM under 14 hrs light and 10 hrs dark condition and measured at 5 dpf stage by microscopic analysis
AID477872Displacement of [3H]PbTx-3 from rat brain synaptosome voltage-sensitive sodium channel site 5 after 1 hr by rapid filtration based scintillation counting2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Characterization of tamulamides A and B, polyethers isolated from the marine dinoflagellate Karenia brevis.
AID254847Inhibitory concentration against synaptosome using [3H]PbTx-32005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry.
AID255219Binding affinity of [3H]PbTx-3 towards synaptosomes2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry.
AID1774642Inhibition of Karenia brevis TrxR assessed as reduction in substrate reduction at 10 to 100 uM using H2O2 as a substrate incubated for 60 mins in the presence of NADPH followed by substrate addition measured for 15 mins by absorbance based assay relative 2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
AID1660539Neurotoxicity in 4 to 5 hpf stage wild type zebrafish AB embryo assessed as irregular inflated swim bladder at 4.5 to 22 nM under 14 hrs light and 10 hrs dark condition and measured at 5 dpf stage by microscopic analysis
AID477879Bronchoconstriction in sheep asthma model assessed as pulmonary airflow resistance at 10 pg/ml administered through aerosol for 20 breaths by pneumotachography relative to control2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Characterization of tamulamides A and B, polyethers isolated from the marine dinoflagellate Karenia brevis.
AID376747Toxicity against Gambusia affinis assessed as mortality at 1 ug/ml after 7.5 min2005Journal of natural products, Jan, Volume: 68, Issue:1
A new polyether ladder compound produced by the dinoflagellate Karenia brevis.
AID1774645Inhibition of Karenia brevis TrxRD3 assessed as reduction in substrate reduction at 40 uM using DTNB as a substrate incubated for 60 mins in the presence of NADPH followed by substrate addition measured for 5 mins by absorbance based assay relative to con2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
AID1774646Inhibition of Karenia brevis TrxR assessed as reduction in substrate reduction using H2O2 as a substrate incubated for 60 mins in the presence of NADPH followed by substrate addition measured for 15 mins by absorbance based assay2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
AID690188Inhibition of MTX-induced calcium influx in rat glioma C6 cells using 45CaCl2 incubated for 12 mins prior to MTX-challenge measured after 12 mins by scintillation counting2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Artificial ladder-shaped polyethers that inhibit maitotoxin-induced Ca2+ influx in rat glioma C6 cells.
AID1660542Neurotoxicity in 4 to 5 hpf stage wild type zebrafish AB embryo assessed as effect on spasms at 4.5 to 22 nM under 14 hrs light and 10 hrs dark condition and measured at 5 dpf stage by microscopic analysis
AID1774643Inhibition of Karenia brevis TrxR assessed as reduction in substrate reduction at 40 uM using human Trx and insulin as a substrate incubated for 60 mins in the presence of NADPH followed by substrate addition measured for 5 mins by absorbance based assay 2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
AID1774648Binding affinity Karenia brevis TrxR assessed as formation at 7.2 uM by LC-MS/MS analysis2021Journal of natural products, 11-26, Volume: 84, Issue:11
The Marine Neurotoxin Brevetoxin (PbTx-2) Inhibits
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (5.88)18.7374
1990's7 (13.73)18.2507
2000's16 (31.37)29.6817
2010's21 (41.18)24.3611
2020's4 (7.84)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.64 (24.57)
Research Supply Index3.99 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (96.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]